跳至主要内容
临床试验/EUCTR2010-022897-14-DK
EUCTR2010-022897-14-DK进行中(未招募)1 期

A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study. - A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the

St. Olavs University Hospital0 个研究点目标入组 12 人开始时间: 2013年5月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Lung cancer
  • Have a staging CT within 4 weeks of commencement of chemotherapy or chemoradiotherapy (in patients where staging CT is outwith this period, further CT scanning will be undertaken. PET-CTs are also appropriate)
  • 18–75years of age
  • about to start chemotherapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 2

排除标准

  • Renal impairment (serum albumin < 25 g/L or Child-Pugh =10 (pancreatic cancer patients only)), creatinine clearance <30ml/min (estimated using cockroft-gault, creatinine measured within two months of date of consent)
  • Patients who are taking either aspirin, NSAID or Cox 2 inhibitors prior to study entry
  • Women during pregnancy, breastfeeding or who are of child-bearing potential (that is not postmenopausal or permanently sterilised) age and who do not use adequate contraception (oral, injected or implanted or hormonal methods of contraception’s, intrauterine device and barrier method)

研究者

发起方
St. Olavs University Hospital

相似试验